2016
DOI: 10.18632/oncotarget.10912
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of C16orf74 is involved in aggressive pancreatic cancers

Abstract: Clinical outcome of pancreatic ductal adenocarcinoma (PDAC) has not been improved in the last three decades due to the lack of effective molecular-targeted drugs. To identify a novel therapeutic target for PDAC, we have performed genome-wide anamysis and found that Homo sapiens chromosome 16 open reading frame 74 (C16orf74) was up-regulated in the vast majority of PDAC. Overexpression of C16orf74protein detected by immunohistochemical analysis was an independent prognostic factor for patients with PDAC. The kn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
20
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(25 citation statements)
references
References 42 publications
5
20
0
Order By: Relevance
“…Analysis of the peptide from CACNA1H (which contains a previously identified LxVP sequence (Huang et al, 2013)) showed that co-purification with CN WT was reduced upon mutation of LxV or IxIT residues ( Figure 1H), and that binding to CN NIR or CN WF was significantly reduced (undetectable) relative to CN WT ( Figure S2A). Thus, both PxIxIT and LxVP-type binding modes were evident in this single peptide, properties also displayed by the peptide from C16orf74 (previously identified as a PxIxIT (Nakamura et al, 2017)) (data not shown).…”
Section: Validation Of Peptide Binding To Cnsupporting
confidence: 61%
“…Analysis of the peptide from CACNA1H (which contains a previously identified LxVP sequence (Huang et al, 2013)) showed that co-purification with CN WT was reduced upon mutation of LxV or IxIT residues ( Figure 1H), and that binding to CN NIR or CN WF was significantly reduced (undetectable) relative to CN WT ( Figure S2A). Thus, both PxIxIT and LxVP-type binding modes were evident in this single peptide, properties also displayed by the peptide from C16orf74 (previously identified as a PxIxIT (Nakamura et al, 2017)) (data not shown).…”
Section: Validation Of Peptide Binding To Cnsupporting
confidence: 61%
“…Consistent with our findings that acidic residues at the -1 position decrease affinity, JNK kinase regulates CN signaling by phosphorylating a serine that immediately precedes the PxIxIT of NFAT4 40 . Similarly, our demonstration that phosphorylated residues downstream of the core PxIxIT sequence at position 9 enhance PVIVIT affinity echoes observations that phosphorylation of at threonine in this position is required for binding of CN to a PxIxIT site in C16ORF74, and for its ability to promote invasiveness of pancreatic ductal adenocarcinoma (PDAC) 41 . This positive effect on binding is context-dependent, increasing PVIVIT binding 50-fold but having little or no effect on other PxIxIT sequences, reinforcing the importance of systematic analyses for generating predictive information.…”
Section: Discussionsupporting
confidence: 74%
“…For example, FK866, a non-competitive highly specific inhibitor of NAMPT, shows potent anti-tumor activity both in vitro and in vivo [ 61 ] on pancreatic cancer samples overexpressing NAMPT mRNA. Among the other genes of our signature upregulated in STS samples are C16orf74 and KRT13 , which are associated with poor OS in pancreatic [ 62 ] and prostate [ 63 ] cancers.…”
Section: Discussionmentioning
confidence: 99%